Here, we provide in vitro and in vivo evidence that the HDAC inhibitor vorinostat sensitizes mesenchymal-like TNBC to AFP464, at least in part, through reactivation of ERα expression and restoration of AhR responsiveness to AF. Here, HDAC9 is linked to atrial fibrillation.